Introduction
Adhesive capsulitis of the shoulder, commonly known as frozen shoulder, was first described by Duplay 1 and
Adhesive capsulitis of the shoulder AH Leung * , GE Ayana then by Codman 2 . The former termed the condition scapulohumeral periarthritis, while the latter compiled a case series which featured pain in the shoulder of insidious onset, limiting range of movement globally, little local tenderness, lack of radiographic abnormalities and atrophy of the spinati.
Codman's description remains the clinical diagnostic criteria of frozen shoulder to this day.
In this article we aim to critically appraise the existing evidence about this common shoulder condition with specific focus on recently published evidence.
Discussion

Epidemiology
The incidence and prevalence of frozen shoulder has not been accurately determined due to the lack of population based data analysis. Historically experts believed that it affects 2-10% of the population 3 and makes up around 5% of upper limb specialist referrals in the UK 4 . Recent population data from the UK suggest the incidence from 2 to 3 per 1000 and this is increasing in women of a younger age 5 . The true incidence may be higher as many patients delay seeking medical attention. It affects more woman then men, and age of onset is usually in the fifth decade 6 .
Primary and secondary frozen shoulder
Frozen shoulder can be classified as primary, or idiopathic and secondary. The relationship between diabetes mellitus and frozen shoulder has been extensively studied. The prevalence of frozen shoulder in diabetics is as high as 71.5% 
Pathophysiology
In idiopathic frozen shoulder, despite termed adhesive capsulitis, adhesions are not a feature, but rather inflammation and contracture of the joint capsule 11 . In early stages, the macroscopic appearances are of inflammation and thickening of the capsule, which gradually leads to fibrosis with time 12 . The coracohumeral ligament has been found to be tight and shortened 13 . What drives the underlying disease process remains unclear. Hand 16 recently suggested that subacromial bursitis may be contributory to the development of frozen shoulder as elevated levels of inflammatory cytokines were found in both capsular and bursal tissues of symptomatic patients. Xu and colleagues 17 detected neoinnervation and neoangiogenesis in the capsule which may be responsible for the increased level of pain. colleagues' 28 ,concluded corticosteroid injections may have a role in relieving symptoms in the short term. Carette and colleagues 29 found corticosteroid injections under fluoroscopy, combined with or without physiotherapy, are effective in providing early relief and improvement in the shoulder pain and disability index. A randomised controlled trial by Ryans and colleagues 30 , concluded triamcinolone is useful in limiting shoulder disability as measured by the shoulder disability questionnaire score. The dosage of triamcinolone injected does not seem to affect outcome in a randomised controlled trial by Yoon and colleagues 31 . There have also been several recent studies looking into the role of corticosteroid injections in diabetic patients. Roh and colleagues 32 performed a randomised controlled trial into the use of corticosteroid injections in diabetic patients and concluded this was effective in early relief of pain and restoration of movement up to 12 weeks. Dehghan and colleagues 33 compared corticosteroid injections and Non-steroidal anti-inflammatory drugs for diabetic patients and found little difference in outcomes. Finally, the site of corticosteroid injection, whether it is intra-articular, subacromial or both, seem to provide equivalent and faster pain relief than oral medication, as shown in a randomised controlled trial by Shin and colleagues 34 . Patients with frozen shoulder are often referred to physiotherapy. Evidence in the literature does not support utilising physiotherapy alone as mainstay of treatment and is demonstrated in trials by Bulgen and colleagues 28 and Carette and colleagues 29 . Conversely, intensive physiotherapy may actually be harmful, as Diercks and colleagues 35 have shown this to be related to a worse outcome measured by pain and the Constant score, when compared with supervised neglect.
Clinical features and diagnosis
In the majority of patients, the diagnosis of frozen shoulder is made clinically by using Codman 21 and T2 hyperintensity of the inferior glenohumeral ligament 22 have also been associated with frozen shoulder.
Natural history
Classically three stages have been described for frozen shoulder: 'freezing', 'frozen' or adhesive phase and 'thawing' or resolution 10, 12 . In the first stage, the shoulder is exquisitely painful, analgesia is ineffective and stiffness sets in. In the 'frozen' phase, the pain begins to subside but the shoulder remains stiff. In the 'thawing' phase, the range of movement is gradually regained.
There have been many studies looking into the natural history and disease duration for frozen shoulder, which can vary greatly between individuals. Shaffer and colleagues 23 subjectively and objectively evaluated a cohort with a mean follow-up time of 7 years with non-operative treatment and found that half of the cohort still experienced pain or stiffness at their last follow-up. More recent evidence appears to offer a brighter outlook into the condition. Hand and colleagues 6 observed a 48 h onset of symptoms for their cohort, and from 1 to 3 years for symptoms to peak and resolve, as measured with improvements in the Oxford Shoulder Score. Vastamäki and colleagues 24 observed a cohort for a mean of 9 years, and concluded that even without any treatment, symptoms resolve after 15 months and the vast majority in the cohort regained normal function.
Treatment
Non-operative
Two randomised controlled trials exist in the literature examining the role of oral corticosteroids in providing symptomatic relief in frozen shoulder, both of which concluded this may be useful only in the short term. Blockey and colleague 25 conducted a controlled trial of 32 patients and assessed them for 18 weeks. They concluded oral corticosteroids may provide some symptomatic relief and reduce the need for manipulation. Half a century later, Buchbinder and colleagues 26 conducted a randomised controlled trial with oral prednisolone. They concluded corticosteroids may provide a short-term relief but this is only observed within 6 weeks from onset.
The role of corticosteroid injections in the management of frozen shoulder is still subject to much debate but has been well investigated. Distension arthrography has been discussed in the literature since the 1960s. Some experienced clinicians have recommended this as the first line of surgical management for both diagnostic and therapeutic purposes 12 . However, the quality of evidence in the literature is limited to mainly case series 42 and often with poor outcome measures and inadequate follow-up period. Mulcahy and colleagues 43 have the largest case series of 51 patients with a follow-up period of 6 months and they concluded distension arthrography which may be useful in patients without a cuff tear and limited external rotation. A recent paper by Park and colleagues 44 utilised ultrasonography for capsular distension in a cohort study and concluded this is as effective as steroid injection for pain relief and regaining movement.
Arthroscopic release has become more popular in the past 20 years and originally devised for patients who have failed to respond to nonoperative treatment or MUA. The procedure includes releasing contractures at the rotator interval, within the capsule and in the axillary pouch 11, 12 . Subacromial decompression with acromioplasty may be performed at the same time. Previous evidence often reported single cohort outcomes, such as the one by Warner and colleagues 45 . In Ogilvie-Harris and colleagues' study 46 , they compared MUA against arthroscopic release and found better pain relief and improvement in function with the latter. This study remains one of the few comparing cohorts receiving different operative treatment. Arthroscopic release has also been combined with MUA in studies featuring case series by Castellarin and colleagues 36 and Baum and colleagues 47 . In the recent years, more evidence has come to light with regards to outcomes in the longer term for arthroscopic release. Baums and colleagues 47 observed a cohort for a median of 36 months with improvements in pain and functional scores. Le Lievre and colleagues 48 concluded from their study with a mean follow-up of 7 years that arthroscopic release is safe and effective in improving pain and function. Dattani 
Conclusion
Adhesive capsulitis of the shoulder remains one of the commonest shoulder pathologies and a leading presentation to general practice and upper limb orthopaedic specialists. The pathophysiology is poorly understood but is likely to involve an inflammatory process with fibroblastic proliferation. The natural history can be divided into three classic stages. Non-operative management with corticosteroid injections may be helpful. Surgically, manipulation under anaesthesia is a successful treatment with increasing evidence of a good outcome maintained in the long term. Evidence behind arthroscopic release is gradually being published supporting it as an effective alternative. The overall quality of evidence is low, pointing to a need for randomised controlled trials to compare between the newer management options.
